Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice.

Pacher P, Bátkai S, Kunos G.

J Physiol. 2004 Jul 15;558(Pt 2):647-57. Epub 2004 Apr 30.

2.

The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor.

Williams MA, Smith SA, O'Brien DE, Mitchell JH, Garry MG.

J Physiol. 2008 Feb 1;586(3):835-45. Epub 2007 Dec 6.

3.

Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.

Pacher P, Bátkai S, Osei-Hyiaman D, Offertáler L, Liu J, Harvey-White J, Brassai A, Járai Z, Cravatt BF, Kunos G.

Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H533-41. Epub 2005 Apr 8.

4.
5.

Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence.

de Lago E, de Miguel R, Lastres-Becker I, Ramos JA, Fernández-Ruiz J.

Brain Res. 2004 May 8;1007(1-2):152-9.

PMID:
15064146
6.

The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder.

Saitoh C, Kitada C, Uchida W, Chancellor MB, de Groat WC, Yoshimura N.

Eur J Pharmacol. 2007 Sep 10;570(1-3):182-7. Epub 2007 Jun 5.

7.

Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.

Kawahara H, Drew GM, Christie MJ, Vaughan CW.

Br J Pharmacol. 2011 Jul;163(6):1214-22. doi: 10.1111/j.1476-5381.2010.01157.x.

8.

Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.

Engel MA, Izydorczyk I, Mueller-Tribbensee SM, Becker C, Neurath MF, Reeh PW.

Neuropeptides. 2011 Jun;45(3):229-37. doi: 10.1016/j.npep.2011.03.005. Epub 2011 Apr 22.

PMID:
21514666
9.

Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.

Domenicali M, Ros J, Fernández-Varo G, Cejudo-Martín P, Crespo M, Morales-Ruiz M, Briones AM, Campistol JM, Arroyo V, Vila E, Rodés J, Jiménez W.

Gut. 2005 Apr;54(4):522-7.

11.
13.

A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats.

Zakrzeska A, Schlicker E, Baranowska M, Kozłowska H, Kwolek G, Malinowska B.

Br J Pharmacol. 2010 Jun;160(3):574-84. doi: 10.1111/j.1476-5381.2009.00579.x. Epub 2010 Jan 25.

14.
15.

Cardiovascular pharmacology of anandamide.

Högestätt ED, Zygmunt PM.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):343-51. Review.

PMID:
12052048
16.

Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats.

Kwolek G, Zakrzeska A, Schlicker E, Göthert M, Godlewski G, Malinowska B.

Br J Pharmacol. 2005 Jul;145(5):567-75.

17.

Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.

Tzavara ET, Li DL, Moutsimilli L, Bisogno T, Di Marzo V, Phebus LA, Nomikos GG, Giros B.

Biol Psychiatry. 2006 Mar 15;59(6):508-15. Epub 2005 Sep 30.

PMID:
16199010
18.

TRPV1, TRPA1, and CB1 in the isolated vagus nerve--axonal chemosensitivity and control of neuropeptide release.

Weller K, Reeh PW, Sauer SK.

Neuropeptides. 2011 Dec;45(6):391-400. doi: 10.1016/j.npep.2011.07.011. Epub 2011 Aug 24.

PMID:
21868092
19.
20.

Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.

Moezi L, Gaskari SA, Liu H, Baik SK, Dehpour AR, Lee SS.

Br J Pharmacol. 2006 Dec;149(7):898-908. Epub 2006 Oct 16.

Supplemental Content

Support Center